Director's $50M Investment in Summit Therapeutics (NASDAQ:SMMT) Signals Confidence
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameSummit Therapeutics PLC
-
Registration countryUnited Kingdom
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









